格隆汇12月15日丨津上机床中国(01651.HK)公告，12月15日耗资488.67万港元回购15万股，每股回购价 32.26-32.74港元。 ...

明源云(00909)发布公告，于2025年12月15日斥资431.74万港元回购140万股。 ...

东方海外国际(00316)发布公告，公司独立非执行董事以及核数委员会及战略发展委员会成员苏锦樑先 生于2025年12月13日辞世。 ...

津上机床中国(01651)发布公告，于2025年12月15日，该公司斥资488.67万港元回购15万股股份，每股回 购价格为32.26-32.74港元。 ...

陆氏集团(越南)(00366)发布公告，本公司董事会主席、联合创始人、执行董事及根据香港联合交易所有 限公司证券上市规则第3.05条项下的授权代表郑嫱女士(郑女士)于2025年12月13日安详辞世，享寿八十 六岁。 ...

御德国际控股(08048)公布，鲍曼曼女士获委任为独立非执行董事，并担任董事会辖下审核委员会及提 名委员会成员;林菲菲女士获委任为独立非执行董事，并担任董事会辖下审计委员会及薪酬委员会成 员，均自2025年12月16日起生效。 ...

Core Insights - Ant Group has officially upgraded its AI health application AQ to "Ant Aifu," marking a strategic shift from "medical AI tools" to "AI health companions" in the digital health sector [1][3] - The new "Aifu" app focuses on a "health+" strategy, boasting over 15 million monthly active users, making it one of the top five AI applications in China and the largest health management AI app [1][5] Strategic Shift - The upgrade signifies a transition from a functional tool to a companion, aiming to meet the unaddressed market demand for health promotion, disease prevention, and out-of-hospital management [1][3] - The product positioning reflects a market logic where AI is not just a cold tool but a trusted companion, enhancing user engagement and long-term value [3][4] Functional Enhancements - Aifu has undergone a systematic restructuring of its features, including a health companionship system that integrates data from various smart devices and allows for personalized health management [4][5] - The health Q&A capability has been upgraded to provide tailored responses based on continuous learning from user data, including a unique "AI clinic" mode for better symptom description [4][5] Platform Connectivity - Aifu emphasizes its role in connecting users with healthcare services rather than replacing doctors, linking to 300,000 real doctors for online consultations and integrating practical features like appointment scheduling and medication purchases [4][5] - The platform has already facilitated over 27 million consultations, showcasing its potential to alleviate pressure on public health systems by providing accessible health education and initial consultations [5][6] Market Positioning - With 55% of its users from third-tier cities, Aifu demonstrates strong penetration in grassroots markets, aligning with China's "Healthy China" strategy to enhance basic health services [5] - The app's daily interaction volume of over 5 million health inquiries indicates a robust demand for professional and convenient AI health services [5][6] Evolution Path - Ant Group's journey from "Anzhener" to "AQ" and now to "Aifu" illustrates a clear evolution in the digital health space, transitioning from regional pilots to nationwide promotion and from single-function tools to integrated ecosystems [5][6]

智通财经APP讯，御德国际控股(08048)公布，鲍曼曼女士获委任为独立非执行董事，并担任董事会辖下 审核委员会及提名委员会成员;林菲菲女士获委任为独立非执行董事，并担任董事会辖下审计委员会及 薪酬委员会成员，均自2025 年 12 月 16 日起生效。 ...

智通财经APP讯，明源云(00909)发布公告，于2025年12月15日斥资431.74万港元回购140万股。 ...

智通财经APP讯，美高梅中国(02282)发布公告，该公司于2025年12月15日注销87.94万股已回购股份。 ...